SMAIO SA
PAR:ALSMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
SMAIO SA
PAR:ALSMA
|
FR |
|
Bon Natural Life Ltd
NASDAQ:BON
|
CN |
|
F
|
First Solar Inc
XMUN:F3A
|
US |
|
A
|
Abby Inc
OTC:ABBY
|
US |
|
E
|
Emira Property Fund Ltd
JSE:EMI
|
ZA |
|
Y
|
Yankuang Energy Group Co Ltd
XMUN:YZCA
|
CN |
|
R
|
Ryman Hospitality Properties Inc
F:4RH
|
US |
Intrinsic Value
Is ALSMA undervalued or overvalued?
See the intrinsic value estimate for SMAIO SA and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What SMAIO Does
SMAIO SA is a medical technology company focused on spinal surgery planning and guidance. It develops software and related tools that help surgeons measure the spine, plan corrective procedures, and choose implant positions before an operation. The company sits in the spine-care value chain between imaging data and the surgical procedure, turning patient scans into planning information that can support better alignment decisions.
- Headquarters
- France FR
- Employees
- 30
- IPO date
- Apr 6, 2022
Earnings Waterfall
SMAIO SA
The intrinsic value for SMAIO SA (ALSMA) under the Base Case is hidden EUR.
Compared with the current market price of 5.5 EUR, the stock appears hidden.